AriSLA Fondazione Italiana di ricerca per la Sclerosi Laterale Amiotrofica-Dep.Neurosciences, Biomedicine and Movement Sciences-University of Verona

Projects
Title	Managers	Starting date
L’utilizzo di esosomi derivati da cellule staminali mesenchimali come nuovo approccio terapeutico per la sclerosi laterale amiotrofica. – Bando Arisla 2016	Raffaella Mariotti	6/1/17
Evaluation of therapeutic potential and homing of adipose tissue stem cells in murine model of familial amyotrophic lateral sclerosis	Raffaella Mariotti	2/12/10

Founding numbers
Year	Number
2017	1
2010	1

Share

Piazzale Ludovico Antonio Scuro 10
37124 Verona
VAT number01541040232
Italian Fiscal Code93009870234

Play store Apple Store

AriSLA Fondazione Italiana di ricerca per la Sclerosi Laterale Amiotrofica